Cellular and Molecular Mechanisms of Autoimmune Disease

Toxicologic Pathology

Volumn 40, Issue 2, 2012, Pages 216-229

  Bolon, Brad ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

autoimmune disease; autoimmunity; autoreactive; mechanisms; tolerance

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 4; INTERLEUKIN 6; POLYCYCLIC HYDROCARBON; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; XENOBIOTIC AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE PREDISPOSITION; GENETIC PREDISPOSITION; HASHIMOTO DISEASE; HUMAN; IMMUNE DYSREGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFERTILITY; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOPROLIFERATIVE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; MYOSITIS; NONHUMAN; PEMPHIGUS VULGARIS; POLLUTANT; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SCLERODERMA; SUPPRESSOR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; THYROIDITIS; UNITED STATES; VASCULITIS;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; SELF TOLERANCE;

EID: 84858763324     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311428481     Document Type: Article

References (156)

1. Altmann D. M. Sansom D. Marsh S. G. (1991). What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 12, 267–70.
2. Ayer L. M. Edworthy S. M. Fritzler M. J. (1993). Effect of procainamide and hydralazine on poly (ADP-ribosylation) in cell lines. Lupus 2, 167–72.
3. Bach J. F. (2001). Protective role of infections and vaccinations on autoimmune diseases. J Autoimmunity 16, 347–53.
4. Becker J. B. Monteggia L. M. Perrot-Sinal T. S. Romeo R. D. Taylor J. R. Yehuda R. Bale T. L. (2007). Stress and disease: Is being female a predisposing factor? J Neurosci 27, 11851–1855.
5. Beeson P. B. (1994). Age and sex associations of 40 autoimmune diseases. Am J Med 96, 457–62.
6. Billingham R. E. Brent L. Medawar P. B. (1953). Actively acquired tolerance of foreign cells. Nature 172, 603–06.
7. Bird J. J. Brown D. R. Mullen A. C. Moskowitz N. H. Mahowald M. A. Sider J. R. Gajewski T. F. Wang C. R. Reiner S. L. (1998). Helper T cell differentiation is controlled by the cell cycle. Immunity 9, 229–37.
8. Boberg K. M. Chapman R. W. Hirschfield G. M. Lohse A. W. Manns M. P. Schrumpf E. (2011). Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 54, 374–85.
9. Bolon B. Stolina M. King C. Middleton S. Gasser J. Zack D. Feige U. (2011). Rodent preclinical models for developing novel antiarthritic molecules: Comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol 2011, 569068.
10. Borchers A. Ansari A. A. Hsu T. Kono D. H. Gershwin M. E. (2000). The pathogenesis of autoimmunity in New Zealand mice. Sem Arthritis Rheum 29, 385–99.
11. Boren E. Gershwin M. E. (2004). Inflamm-aging: Autoimmunity, and the immune-risk phenotype. Autoimmun Rev 3, 401–06.
12. Boyton R. J. Altmann D. M. (2002). Transgenic models of autoimmune disease. Clin Exp Immunol 127, 4–11.
13. Bretscher P. Cohn M. (1970). A theory of self-nonself discrimination. Science 169, 1042–049.
14. Burnet F. M. (1959). The Clonal Selection Theory of Acquired Immunity. Vanderbilt University Press, Nashville, TN.
15. Chehadeh W. Weill J. Vantyghem M. C. Alm G. Lefebvre J. Wattre P. Hober D. (2000). Increased level of interferon-α in blood of patients with insulin-dependent diabetes mellitus: Relationship with coxsackievirus B infection. J Infect Dis 181, 1929–939.
16. Christen U. Quinn J. Yeaman S. J. Kenna J. G. Clarke J. B. Gandolfi A. J. Gut J. (1994). Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. Molecular mimicry of trifluoroacetyl-lysine by lipoic acid. Eur J Biochem 223, 1035–047.
17. Christie D. J. (1993). Specificity of drug-induced immune cytopenias. Transfusion Med Rev 7, 230–41.
18. Coornaert B. Carpentier I. Beyaert R. (2009). A20: Central gatekeeper in inflammation and immunity. J Biol Chem 284, 8217–221.
19. Craft J. Fatenejad S. (1997). Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum 40, 1374–382.
20. Cutolo M. Masi A. T. (2005). Circadian rhythms and arthritis. Rheum Dis Clin N Am 31, 115–29, ix–x.
21. Cutolo M. Straub R. H. (2009). Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthritis Res Ther 11, 218.
22. Cutolo M. Sulli A. Seriolo B. Accardo S. Masi A. T. (1995). Estrogens, the immune response and autoimmunity. Clin Exp Rheum 13, 217–26.
23. Cutolo M. Villaggio B. Foppiani L. Briata M. Sulli A. Pizzorni C. Faelli F. Prete C. Felli L. Seriolo B. Giusti M. (2000). The hypothalamic-pituitary-adrenal and -gonadal axes in rheumatoid arthritis. Ann N Y Acad Sci 917, 835–43.
24. Da Silva J. A. (1995). Sex hormones, glucocorticoids and autoimmunity: Facts and hypotheses. Ann Rheum Dis 54, 6–16.
25. Damsker J. M. Hansen A. M. Caspi R. R. (2010). Th1 and Th17 cells: Adversaries and collaborators. Ann N Y Acad Sci 1183, 211–21.
26. Dardalhon V. Korn T. Kuchroo V. K. Anderson A. C. (2008). Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 31, 252–56.
27. de Carvalho J. F. Pereira R. M. Gershwin M. E. (2009). Hematopoietic cell transplants in autoimmunity. Israel Med Assoc J 11, 629–32.
28. del Puente A. Knowler W. C. Pettitt D. J. Bennett P. H. (1988). The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum 31, 1239–244.
29. Dell A. Antone S. M. Gauntt C. J. Crossley C. A. Clark W. A. Cunningham M. W. (1991). Autoimmune determinants of rheumatic carditis: Localization of epitopes in human cardiac myosin. Eur Heart J 12(Suppl D), 158–62.
30. Ebringer A. Wilson C. (2000). HLA molecules, bacteria and autoimmunity. J Med Microbiol 49, 305–11.
31. Egwuagu C. E. (2009). STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 47, 149–56.
32. Elenkov I. J. Chrousos G. P. (2002). Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966, 290–303.
33. Elenkov I. J. Iezzoni D. G. Daly A. Harris A. G. Chrousos G. P. (2005). Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12, 255–69.
34. Elenkov I. J. Kvetnansky R. Hashiramoto A. Bakalov V. K. Link A. A. Zachman K. Crane M. Jezova D. Rovensky J. Dimitrov M. A. Gold P. W. Bonini S. Fleisher T. Chrousos G. P. Wilder R. L. (2008). Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: Presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans? J Immunol 181, 1737–745.
35. Elenkov I. J. Webster E. L. Torpy D. J. Chrousos G. P. (1999). Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: Acute and chronic effects. Ann N Y Acad Sci 876, 1–11; discussion 11–13.
36. Ercolini A. M. Miller S. D. (2009). The role of infections in autoimmune disease. Clin Exp Immunol 155, 1–15.
37. Fairweather D. Cihakova D. (2009). Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 33, 222–30.
38. Fancy S. P. Baranzini S. E. Zhao C. Yuk D. I. Irvine K. A. Kaing S. Sanai N. Franklin R. J. Rowitch D. H. (2009). Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23, 1571–585.
39. Farine J. C. (1997). Animal models in autoimmune disease in immunotoxicity assessment. Toxicology 119, 29–35.
40. Fichorova R. N. Boulanov I. D. (1996). Anti-seminal plasma antibodies associated with infertility: I. Serum antibodies against normozoospermic seminal plasma in patients with unexplained infertility. Am J Reprod Immunol 36, 198–203.
41. Fietta P. Delsante G. Quaini F. (2009). Hematologic manifestations of connective autoimmune diseases. Clin Exp Rheumatol 27, 140–54.
42. Fitzgerald A. A. Leclercq S. A. Yan A. Homik J. E. Dinarello C. A. (2005). Rapid responses to anakinra in patients with refractory adult-onset Still’s disease. Arthritis Rheum 52, 1794–803.
43. Flynn J. C. Meroueh C. Snower D. P. David C. S. Kong Y. M. (2007). Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Clin Exp Immunol 147, 547–54.
44. Friedman S. M. Posnett D. N. Tumang J. R. Cole B. C. Crow M. K. (1991). A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthritis Rheum 34, 468–80.
45. Fujii H. Shao L. Colmegna I. Goronzy J. J. Weyand C. M. (2009). Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci USA 106, 4360–365.
46. Gershwin L. J. (2007). Veterinary autoimmunity: Autoimmune diseases in domestic animals. Ann N Y Acad Sci 1109, 109–16.
47. Geva E. Amit A. Lerner-Geva L. Lessing J. B. (1997). Autoimmunity and reproduction. Fertil Steril 67, 599–611.
48. Giarratana N. Penna G. Adorini L. (2007). Animal models of spontaneous autoimmune disease: Type 1 diabetes in the nonobese diabetic mouse. Methods Mol Biol 380, 285–311.
49. Ginn L. R. Lin J. P. Plotz P. H. Bale S. J. Wilder R. L. Mbauya A. Miller F. W. (1998). Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. Arthritis Rheum 41, 400–05.
50. Godessart N. Kunkel S. L. (2001). Chemokines in autoimmune disease. Curr Opin Immunol 13, 670–75.
51. Golovanova N. K. Gracheva E. V. Basharova L. A. Kozlov S. G. Lyakishev A. A. Prokazova N. V. Bergelson L. D. (1998). Autoantibodies to gangliosides in sera of atherosclerotic patients. Clin Chim Acta 272, 197–207.
52. Goronzy J. J. Weyand C. M. (2009). Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther 11, 249.
53. Griem P. Wulferink M. Sachs B. Gonzalez J. B. Gleichmann E. (1998). Allergic and autoimmune reactions to xenobiotics: How do they arise? Immunol Today 19, 133–41.
54. Guilherme L. Dulphy N. Douay C. Coelho V. Cunha-Neto E. Oshiro S. E. Assis R. V. Tanaka A. C. Pomerantzeff P. M. Charron D. Toubert A. Kalil J. (2000). Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. Int Immunol 12, 1063–074.
55. Gutcher I. Becher B. (2007). APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 117, 1119–127.
56. Haak S. Gyulveszi G. Becher B. (2009). Th17 cells in autoimmune disease: Changing the verdict. Immunotherapy 1, 199–203.
57. Harbuz M. S. Richards L. J. Chover-Gonzalez A. J. Marti-Sistac O. Jessop D. S. (2006). Stress in autoimmune disease models. Ann N Y Acad Sci 1069, 51–61.
58. Heward J. Gough S. C. (1997). Genetic susceptibility to the development of autoimmune disease. Clin Sci (Lond) 93, 479–91.
59. Hodgkin P. D. Basten A. (1995). B cell activation, tolerance and antigen-presenting function. Curr Opin Immunol 7, 121–29.
60. Holladay S. D. (1999). Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environ Health Perspec 107(Suppl 5), 687–91.
61. Hsu L. Y. Tan Y. X. Xiao Z. Malissen M. Weiss A. (2009). A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity. J Exp Med 206, 2527–541.
62. Imberti L. Sottini A. Primi D. (1993). T cell repertoire and autoimmune diseases. Immunol Res 12, 149–67.
63. Jacobson D. L. Gange S. J. Rose N. R. Graham N. M. (1997). Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84, 223–43.
64. Jaeckel E. Kretschmer K. Apostolou I. von Boehmer H. (2006). Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunity. Sem Immunol 18, 89–92.
65. Jain N. Nguyen H. Chambers C. Kang J. (2010). Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proc Natl Acad Sci USA 107, 1524–528.
66. Janeway C. A., Jr (1989). Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol 54(Pt 1), 1–13.
67. Janeway C. A. Jr Travers P. Walport M. Shlomchik M. J. (2007). Immunobiology, Garland Science, New York.
68. Karin M. Greten F. R. (2005). NF-κB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5, 749–59.
69. Khare S. D. Luthra H. S. David C. S. (1995). Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking β2-microglobulin: A model of human spondyloarthropathies. J Exp Med 182, 1153–158.
70. Kleinau S. Lorentzen J. Klareskog L. (1995). Role of adjuvants in turning autoimmunity into autoimmune disease. Scand J Rheum 101(Suppl), 179–81.
71. Koetz K. Bryl E. Spickschen K. O’Fallon W. M. Goronzy J. J. Weyand C. M. (2000). T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 97, 9203–208.
72. Kong Y. M. Waldmann H. Cobbold S. Giraldo A. A. Fuller B. E. Simon L. L. (1989). Pathogenic mechanisms in murine autoimmune thyroiditis: Short- and long-term effects of in vivo depletion of CD4+ and CD8+ cells. Clin Exp Immunol 77, 428–33.
73. Koskinas J. Raptis I. Manika Z. Hadziyannis S. (1999). Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis. Eur J Gastroenterol Hepatol 11, 1421–424.
74. Kristinsson S. Y. Landgren O. Samuelsson J. Björkholm M. Goldin L. R. (2010). Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 95, 1216–220.
75. Kronenberg M. (1991). Self-tolerance and autoimmunity. Cell 65, 537–42.
76. Krupica T. Jr Fry T. J. Mackall C. L. (2006). Autoimmunity during lymphopenia: A two-hit model. Clin Immunol 120, 121–28.
77. Kubicka-Muranyi M. Kremer J. Rottmann N. Lubben B. Albers R. Bloksma N. Luhrmann R. Gleichmann E. (1996). Murine systemic autoimmune disease induced by mercuric chloride: T helper cells reacting to self proteins. Int Arch Allergy Immunol 109, 11–20.
78. Lindfors E. Gopalacharyulu P. V. Halperin E. Oresic M. (2009). Detection of molecular paths associated with insulitis and type 1 diabetes in non-obese diabetic mouse. PLoS ONE 4, e7323.
79. Lleo A. Invernizzi P. Gao B. Podda M. Gershwin M. E. (2010). Definition of human autoimmunity—Autoantibodies versus autoimmune disease. Autoimmun Rev 9, A259–66.
80. Lorber M. Gershwin M. E. Shoenfeld Y. (1994). The coexistence of systemic lupus erythematosus with other autoimmune diseases: The kaleidoscope of autoimmunity. Sem Arthritis Rheum 24, 105–13.
81. Luo G. Fan J. L. Seetharamaiah G. S. Desai R. K. Dallas J. S. Wagle N. Doan R. Niesel D. W. Klimpel G. R. Prabhakar B. S. (1993). Immunization of mice with Yersinia enterocolitica leads to the induction of antithyrotropin receptor antibodies. J Immunol 151, 922–28.
82. Luo G. Seetharamaiah G. S. Niesel D. W. Zhang H. Peterson J. W. Prabhakar B. S. Klimpel G. R. (1994). Purification and characterization of Yersinia enterocolitica envelope proteins which induce antibodies that react with human thyrotropin receptor. J Immunol 152, 2555–561.
83. Marleau A. M. Sarvetnick N. (2005). T cell homeostasis in tolerance and immunity. J Leukoc Biol 78, 575–84.
84. Martin-Orozco N. Chung Y. Chang S. H. Wang Y. H. Dong C. (2009). Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 39, 216–24.
85. Matzinger P. (1994). Tolerance, danger, and the extended family. Annu Rev Immunol 12, 991–1045.
86. Matzinger P. (2002). The danger model: A renewed sense of self. Science 296, 301–05.
87. Melner M. H. Feltus F. A. (1999). Autoimmune premature ovarian failure—Endocrine aspects of a T cell disease. Endocrinology 140, 3401–403.
88. Molina V. Shoenfeld Y. (2005). Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38, 235–45.
89. Mondino A. Khoruts A. Jenkins M. K. (1996). The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci USA 93, 2245–252.
90. Mor F. (2007). Treatment of autoimmune disease: Time for a paradigm shift? Arch Immunol Ther Exper 55, 13–8.
91. Mosmann T. R. Schumacher J. H. Street N. F. Budd R. O’Garra A. Fong T. A. Bond M. W. Moore K. W. Sher A. Fiorentino D. F. (1991). Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol Rev 123, 209–29.
92. Mustafa A. Holladay S. D. Goff M. Witonsky S. G. Kerr R. Reilly C. M. Sponenberg D. P. Gogal R. M., Jr. (2008). An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD. Toxicol Appl Pharmacol 232, 51–9.
93. Mustafa A. Holladay S. Witonsky S. Zimmerman K. Manari A. Countermarsh S. Karpuzoglu E. Gogal R. (2011). Prenatal TCDD causes persistent modulation of the postnatal immune response, and exacerbates inflammatory disease, in 36-week-old lupus-like autoimmune SNF1 mice. Birth Def Res Pt B Dev Repro Tox 92, 82–94.
94. Nagata S. Suda T. (1995). Fas and Fas ligand: lpr and gld mutations. Immunol Today 16, 39–43.
95. Niebroj-Dobosz I. Dziewulska D. Janik P. (2006). Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Folia Neuropathol 44, 191–96.
96. Nielen M. M. van Schaardenburg D. Reesink H. W. van de Stadt R. J. van der Horst-Bruinsma I. E. de Koning M. H. Habibuw M. R. Vandenbroucke J. P. Dijkmans B. A. (2004). Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum 50, 380–86.
97. Ochoa-Reparaz J. Mielcarz D. W. Ditrio L. E. Burroughs A. R. Foureau D. M. Haque-Begum S. Kasper L. H. (2009). Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 183, 6041–050.
98. Pacifici R. (2007). T cells and post menopausal osteoporosis in murine models. Arthritis Res Ther 9, 102.
99. Patel A. M. Moreland L. W. (2010). Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy. Drug Design Dev Ther 4, 263–78.
100. Patrick L. (2009). Thyroid disruption: Mechanism and clinical implications in human health. Alt Med Rev 14, 326–46.
101. Pazin M. J. Kadonaga J. T. (1997). What’s up and down with histone deacetylation and transcription? Cell 89, 325–28.
102. Pollard K. M. (2006). Autoantibodies and Autoimmunity. Wiley-VCH Verlag, Weinheim, Germany.
103. Proal A. D. Albert P. J. Marshall T. (2009). Autoimmune disease in the era of the metagenome. Autoimmun Rev 8, 677–81.
104. Punzi L. Betterle C. (2004). Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 71, 275–83.
105. Purrmann J. Arendt G. Cleveland S. Borchard F. Furst W. Gemsa R. Bertrams J. Hengels K. J. (1992). Association of Crohn’s disease and multiple sclerosis. Is there a common background? J Clin Gastroenterol 14, 43–6.
106. Quddus J. Johnson K. J. Gavalchin J. Amento E. P. Chrisp C. E. Yung R. L. Richardson B. C. (1993). Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 92, 38–53.
107. Radbruch A. Lipsky P. E. (2010). Current Concepts in Autoimmunity and Chronic Inflammation. Springer-Verlag, Berlin.
108. Rao T. Richardson B. (1999). Environmentally induced autoimmune diseases: Potential mechanisms. Environ Health Perspect 107(Suppl 5), 737–42.
109. H.C., Rath, H.H., Herfarth, J.S., Ikeda, W.B., Grenther, T.T.J., Hamm, E., Balish, J.D., Taurog, R.E., Hammer, K.H., Wilson, R.B., Sartor, Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats, J Clin Invest, (1996), 98, 945-953
110. Richardson B. Scheinbart L. Strahler J. Gross L. Hanash S. Johnson M. (1990). Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 33, 1665–673.
111. Roitt I. Brostoff J. Male D. Roth D. (2006). Immunology. Mosby (Elsevier), Philadelphia.
112. Ross R. (1990). Mechanisms of atherosclerosis—A review. Adv Nephrol Necker Hosp 19, 79–86.
113. Schiffenbauer J. Soos J. Johnson H. (1998). The possible role of bacterial superantigens in the pathogenesis of autoimmune disorders. Immunol Today 19, 117–20.
114. Schonland S. O. Lopez C. Widmann T. Zimmer J. Bryl E. Goronzy J. J. Weyand C. M. (2003). Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA 100, 13471–3476.
115. Schwartz R. H. (2003). T cell anergy. Annu Rev Immunol 21, 305–34.
116. Segal B.M. (2010). Th17 cells in autoimmune demyelinating disease. Sem Immunopathol 32, 71–7.
117. Senolt L. Vencovsky J. Pavelka K. Ospelt C. Gay S. (2009). Prospective new biological therapies for rheumatoid arthritis. Autoimmun Rev 9, 102–07.
118. Shih D. Q. Targan S. R. (2009). Insights into IBD Pathogenesis. Curr Gastroenterol Rep 11, 473–80.
119. Shinitzky M. Deckmann M. Kessler A. Sirota P. Rabbs A. Elizur A. (1991). Platelet autoantibodies in dementia and schizophrenia. Possible implication for mental disorders. Ann N Y Acad Sci 621, 205–17.
120. Shlomchik M. J. (2009). Activating systemic autoimmunity: B’s, T’s, and Tolls. Curr Opin Immunol 21, 626–33.
121. Shull M. M. Ormsby I. Kier A. B. Pawlowski S. Diebold R. J. Yin M. Allen R. Sidman C. Proetzel G. Calvin D. Annunziata N. Doetschman T. (1992). Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693–99.
122. Singer P. A. Theofilopoulos A. N. (1990). T-cell receptor Vβ repertoire expression in murine models of SLE. Immunol Rev 118, 103–27.
123. Sirota M. Schaub M. A. Batzoglou S. Robinson W. H. Butte A. J. (2009). Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet 5, e1000792.
124. Smith D. A. Germolec D. R. (1999). Introduction to immunology and autoimmunity. Environ Health Perspec 107(Suppl 5), 661–65.
125. Smith H. R. Chused T. M. Steinberg A. D. (1984). Cyclophosphamide-induced changes in the MRL-lpr/lpr mouse: Effects upon cellular composition, immune function, and disease. Clin Immunol Immunopathol 30, 51–61.
126. Spivak B. Schechtman M. Blumensohn R. Schonherz-Pine Y. Yoran-Hegesh R. Deckmann M. Mayer R. Weizman A. Shinitzky M. (2009). Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients—Part I: Young subjects. Neuropsychobiology 60, 44–8.
127. St Clair E. W. (2009). Novel targeted therapies for autoimmunity. Curr Opin Immunol 21, 648–57.
128. Staines D. R. (2008). Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides? Med Hypoth 70, 413–18.
129. Stolina M. Bolon B. Dwyer D. Middleton S. Duryea D. Kostenuik P.J. Feige U. Zack D. J. (2008). The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritis. Biomarkers 13, 692–712.
130. Stolina M. Bolon B. Middleton S. Dwyer D. Brown H. Duryea D. Zhu L. Rohner A. Pretorius J. Kostenuik P. Feige U. Zack D. (2009). The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis. J Clin Immunol 29, 158–74.
131. Street N. E. Mosmann T. R. (1991). Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 5, 171–77.
132. Teachey D. T. Seif A. E. Brown V. I. Bruno M. Bunte R. M. Chang Y. J. Choi J. K. Fish J. D. Hall J. Reid G. S. Ryan T. Sheen C. Zweidler-McKay P. Grupp S. A. (2008). Targeting Notch signaling in autoimmune and lymphoproliferative disease. Blood 111, 705–14.
133. Theofilopoulos A. N. (1995). The basis of autoimmunity: Part II. Genetic predisposition. Immunol Today 16, 150–59.
134. Thomas T. J. Messner R. P. (1986). Effects of lupus-inducing drugs on the B to Z transition of synthetic DNA. Arthritis Rheum 29, 638–45.
135. Trivedi S. Greidinger E. L. (2009). Endosomal Toll-like receptors in autoimmunity: Mechanisms for clinical diversity. Therapy 6, 433–42.
136. Tumang J. R. Cherniack E. P. Gietl D. M. Cole B. C. Russo C. Crow M. K. Friedman S. M. (1991). T helper cell-dependent, microbial superantigen-induced murine B cell activation: Polyclonal and antigen-specific antibody responses. J Immunol 147, 432–38.
137. Turbyville J. C. Rao V. K. (2010). The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance. Autoimmun Rev 9, 488–93.
138. Turkstra E. Ng S. K. Scuffham P. A. (2011). A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis. Curr Med Res Opin 27, 1885–897.
139. Turnbaugh P. J. Ley R. E. Hamady M. Fraser-Liggett C. M. Knight R. Gordon J. I. (2007). The human microbiome project. Nature 449, 804–10.
140. Van Loveren H. Vos J. G. Germolec D. Simeonova P. P. Eijkemanns G. McMichael A. J. (2001). Epidemiologic associations between occupational and environmental exposures and autoimmune disease: Report of a meeting to explore current evidence and identify research needs. Int J Hyg Environ Health 203, 483–95.
141. von Herrath M. G. Dyrberg T. Oldstone M. B. (1996). Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 98, 1324–331.
142. Wagner G. Laufer S. (2006). Small molecular anti-cytokine agents. Medicinal Res Rev 26, 1–62.
143. Waldner H. (2009). The role of innate immune responses in autoimmune disease development. Autoimmun Rev 8, 400–04.
144. Waldor M. K. Sriram S. Hardy R. Herzenberg L. A. Lanier L. Lim M. Steinman L. (1985). Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science 227, 415–17.
145. Wang J. Maldonado M. A. (2006). The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol 3, 255–61.
146. Wenzel B. E. Heesemann J. Wenzel K. W. Scriba P. C. (1988). Antibodies to plasmid-encoded proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet 1, 56.
147. Westbrook A. M. Szakmary A. Schiestl R. H. (2010). Mechanisms of intestinal inflammation and development of associated cancers: Lessons learned from mouse models. Mutat Res 705, 40–59.
148. Weyand C. M. Fujii H. Shao L. Goronzy J. J. (2009). Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol 5, 583–88.
149. Wilde B. Thewissen M. Damoiseaux J. van Paassen P. Witzke O. Tervaert J. W. (2010). T cells in ANCA-associated vasculitis: What can we learn from lesional versus circulating T cells? Arthritis Res Ther 12, 204.
150. Wu J. Zhou T. Zhang J. He J. Gause W. C. Mountz J. D. (1994). Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc Natl Acad Sci U S A 91, 2344–348.
151. Wu L. Van Kaer L. (2009). Natural killer T cells and autoimmune disease. Curr Mol Med 9, 4–14.
152. Xu Q. Kiechl S. Mayr M. Metzler B. Egger G. Oberhollenzer F. Willeit J. Wick G. (1999). Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: Clinical significance determined in a follow-up study. Circulation 100, 1169–174.
153. Yoshida S. Gershwin M. E. (1993). Autoimmunity and selected environmental factors of disease induction. Sem Arthritis Rheum 22, 399–419.
154. Youinou P. Taher T. E. Pers J. O. Mageed R. A. Renaudineau Y. (2009). B lymphocyte cytokines and rheumatic autoimmune disease. Arthritis Rheum 60, 1873–880.
155. Yu X. Wester-Rosenlof L. Gimsa U. Holzhueter S. A. Marques A. Jonas L. Hagenow K. Kunz M. Nizze H. Tiedge M. Holmdahl R. Ibrahim S. M. (2009). The mtDNA nt7778 G/T polymorphism affects autoimmune diseases and reproductive performance in the mouse. Hum Mol Genet 18, 4689–698.
156. Yung R. Williams R. Johnson K. Phillips C. Stoolman L. Chang S. Richardson B. (1997). Mechanisms of drug-induced lupus. III. Sex-specific differences in T cell homing may explain increased disease severity in female mice. Arthritis Rheum 40, 1334–343.